Sound Wave Innovation

About Sound Wave Innovation

Sound Wave Innovation (SWI) is a pioneering startup specializing in therapeutic medical devices, with a strong partnership with Tohoku University. The company focuses on the development and clinical studies of LIPUS (Low-Intensity Pulsed Ultrasound) and SWCS (Shock Wave Catheter System) technologies, which were innovated by Professor Emeritus Hiroaki Shimokawa's group. These technologies offer less invasive treatment options compared to traditional methods. LIPUS, in particular, uses low-intensity pulsed ultrasonic waves to stimulate vascular endothelial cells, enhancing the production of eNOS (endothelial nitric oxide synthase) and VEGF (vascular endothelial growth factor). This makes it a promising treatment for conditions related to microcirculatory disorders, including mild dementia and severe angina. The company aims to commercialize these technologies in collaboration with global medical device companies. SWI's business model involves developing these advanced medical devices and seeking regulatory approval to bring them to market. Revenue is generated through partnerships, licensing agreements, and direct sales of their innovative devices. The market for these technologies includes healthcare providers, hospitals, and specialized medical centers focused on treating cardiovascular and neurological conditions.